Clinical Trial Detail

NCT ID NCT02479178
Title A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors BIND Therapeutics
Indications

cervical cancer

urethra transitional cell carcinoma

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

cholangiocarcinoma

head and neck squamous cell carcinoma

bile duct carcinoma

Therapies

BIND-014

Age Groups: adult

No variant requirements are available.